Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy

American Journal of Cardiology

Volumn 111, Issue 2, 2013, Pages 250-257

  Saguner, Ardan M ^a   Medeiros Domingo, Argelia ^a   Schwyzer, Moritz A ^a   On, Chol Jun ^a   Haegeli, Laurent M ^a   Wolber, Thomas ^a,b   Hürlimann, David ^a   Steffel, Jan ^a   Krasniqi, Nazmi ^a   Rüeger, Sina ^c   Held, Leonhard ^c   Lüscher, Thomas F ^a,b   Brunckhorst, Corinna ^a   Duru, Firat ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SUDDEN DEATH;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; DISEASE-FREE SURVIVAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SWITZERLAND; TACHYCARDIA, VENTRICULAR; TIME FACTORS;

EID: 84872010074     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.09.025     Document Type: Article

References (30)

1. K. Lemola, C. Brunckhorst, U. Helfenstein, E. Oechslin, R. Jenni, and F. Duru Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre Heart 91 2005 1167 1172
2. J.P. Piccini, D. Dalal, A. Roguin, C. Bomma, A. Cheng, K. Prakasa, J. Dong, C. Tichnell, C. James, S. Russell, J. Crosson, R.D. Berger, J.E. Marine, G. Tomaselli, and H. Calkins Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia Heart Rhythm 2 2005 1188 1194
3. T. Pezawas, G. Stix, J. Kastner, B. Schneider, M. Wolzt, and H. Schmidinger Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up Int J Cardiol 107 2006 360 368
4. D. Corrado, H. Calkins, M.S. Link, L. Leoni, S. Favale, M. Bevilacqua, C. Basso, D. Ward, G. Boriani, R. Ricci, J.P. Piccini, D. Dalal, M. Santini, G. Buja, S. Iliceto, N.A. Estes III, T. Wichter, W.J. McKenna, G. Thiene, and F.I. Marcus Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia Circulation 122 2010 1144 1152
5. A. Bhonsale, C.A. James, C. Tichnell, B. Murray, D. Gagarin, B. Philips, D. Dalal, R. Tedford, S.D. Russell, T. Abraham, H. Tandri, D.P. Judge, and H. Calkins Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention J Am Coll Cardiol 58 2011 1485 1496
6. F.I. Marcus, W.J. McKenna, D. Sherrill, C. Basso, B. Bauce, D.A. Bluemke, H. Calkins, D. Corrado, M.G. Cox, J.P. Daubert, G. Fontaine, K. Gear, R. Hauer, A. Nava, M.H. Picard, N. Protonotarios, J.E. Saffitz, D.M. Sanborn, J.S. Steinberg, H. Tandri, G. Thiene, J.A. Towbin, A. Tsatsopoulou, T. Wichter, and W. Zareba Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814
7. L. Constantin, J.B. Martins, M.G. Kienzle, S.L. Brownstein, M.L. McCue, and R.C. Hopson Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents Pacing Clin Electrophysiol 12 1989 776 783
8. B. Brembilla-Perrot, J. Donetti, A.T. de la Chaise, N. Sadoul, E. Aliot, and Y. Juilliere Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy Am Heart J 121 1991 1124 1131
9. J.P. Bourke, D.A. Richards, D.L. Ross, M.A. McGuire, and J.B. Uther Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol 75 1995 431 435
10. J. Reisinger, S.W. Dubrey, M. Lavalley, M. Skinner, and R.H. Falk Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement J Am Coll Cardiol 30 1997 1046 1051
11. B. Pinamonti, A.M. Dragos, S.A. Pyxaras, M. Merlo, A. Pivetta, G. Barbati, A. Di Lenarda, T. Morgera, L. Mestroni, and G. Sinagra Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry Eur Heart J 32 2011 1105 1113
12. J. Steffel, R. Kobza, M. Namdar, T. Wolber, C. Brunckhorst, T.F. Luscher, R. Jenni, and F. Duru Electrophysiological findings in patients with isolated left ventricular non-compaction Europace 11 2009 1193 1200
13. D.V. Exner, S.L. Pinski, D.G. Wyse, E.G. Renfroe, D. Follmann, M. Gold, K.J. Beckman, J. Coromilas, S. Lancaster, and A.P. Hallstrom Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial Circulation 103 2001 2066 2071
14. A.M. Saguner, S. Dur, M. Perrig, U. Schiemann, A.E. Stuck, U. Burgi, P. Erne, and A.W. Schoenenberger Risk factors promoting hypertensive crises: evidence from a longitudinal study Am J Hypertens 23 2010 775 780
15. M.S. Link, P.J. Wang, C.J. Haugh, M.K. Homoud, C.B. Foote, X.B. Costeas, and N.A. Estes III Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators J Interv Card Electrophysiol 1 1997 41 48
16. H. Heidbuchel, J. Hoogsteen, R. Fagard, L. Vanhees, H. Ector, R. Willems, and J. Van Lierde High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratification Eur Heart J 24 2003 1473 1480
17. A. Roguin, C.S. Bomma, K. Nasir, H. Tandri, C. Tichnell, C. James, J. Rutberg, J. Crosson, P.J. Spevak, R.D. Berger, H.R. Halperin, and H. Calkins Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 43 2004 1843 1852
18. Y. Iesaka, A. Nogami, K. Aonuma, J. Nitta, Y.H. Chun, H. Fujiwara, and M. Hiraoka Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction Am J Cardiol 65 1990 1057 1063
19. T. Matsushita, S. Chun, L.B. Liem, K.J. Friday, and R.J. Sung Limited predictive value of inducible sustained ventricular tachycardia for future occurrence of spontaneous ventricular tachycardia in patients with coronary artery disease and relatively preserved cardiac function J Electrocardiol 36 2003 205 211
20. T. Matsushita, S. Chun, L.B. Liem, K.J. Friday, and R.J. Sung Significance of inducible ventricular flutter/fibrillation in risk stratification in patients with coronary artery disease Int J Cardiol 94 2004 67 71
21. D. Wietholt, M. Block, F. Isbruch, D. Bocker, M. Borggrefe, M. Shenasa, and G. Breithardt Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator J Am Coll Cardiol 21 1993 885 894
22. S. Peters, and G.H. Reil Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia Eur Heart J 16 1995 77 80
23. B. Pinamonti, A. Di Lenarda, G. Sinagra, F. Silvestri, R. Bussani, and F. Camerini Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group Am Heart J 129 1995 412 415
24. P. Turrini, D. Corrado, C. Basso, A. Nava, B. Bauce, and G. Thiene Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy Circulation 103 2001 3075 3080
25. J.S. Hulot, X. Jouven, J.P. Empana, R. Frank, and G. Fontaine Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy Circulation 110 2004 1879 1884
26. W.H. Frishman Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens Cardiol Rev 15 2007 257 263
27. G.E. Wetzels, P.J. Nelemans, J.S. Schouten, B.L. van Wijk, and M.H. Prins All that glistens is not gold: a comparison of electronic monitoring versus filled prescriptions - an observational study BMC Health Serv Res 6 2006 8
28. A. Pelliccia, D. Corrado, H.H. Bjornstad, N. Panhuyzen-Goedkoop, A. Urhausen, F. Carre, A. Anastasakis, L. Vanhees, E. Arbustini, and S. Priori Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis Eur J Cardiovasc Prev Rehabil 13 2006 876 885
29. A. Cordero, V. Bertomeu-Martinez, P. Mazon, L. Facila, V. Bertomeu-Gonzalez, P. Conthe, and J.R. Gonzalez-Juanatey Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents Cardiovasc Ther 28 2010 15 22
30. K. Hodgkinson, E. Dicks, S. Connors, T.L. Young, P. Parfrey, and D. Pullman Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease Genet Med 11 2009 859 865